Is Aphria (TSX:APHA) Stock an Undervalued Bargain?

Summer may be here, but the sun is not shining on marijuana shareholders. After a series of quarterly reports that missed analyst expectations, the sector as a whole began tumbling, with Horizons Medical Marijuana Life Science ETF sliding 29% since March. While the marijuana sector is growing faster than ever, expenses are beginning to spiral out of control, with no…

Read More

The 3 Worst-Performing Marijuana Stocks of 2019

This year might go down in history as the year that marijuana stocks started to diverge. After 2018, which saw small- and large-cap stocks move together as a class, different producers began to rise or fall on their own merits rather than on sentiment toward marijuana stocks as a whole. Now, almost halfway through 2019, we’re beginning to see which…

Read More

10 Cannabis ETFs to Play the Marijuana Boom

Cannabis stocks have had a great start through the first five months of 2019. As we enter the first full year of Canada’s recreational cannabis legalization and prepare for the “second wave” this October, investors have seen overall strong returns despite the early supply issues. In the U.S., more states continue to warm up to the idea of loosening cannabis…

Read More

Valens GroWorks Corp. (CSE: VGW) (OTCQB: VGWCF) Looks Ready For a Breather Amid Melt-Up

So far in 2019, marijuana has been the place to be, as cannabis stocks have largely outperformed the overall market thus far through the end of April 2019. Two of the largest cannabis ETFs are up over 40% year-to-date: ETFMG Alternative Harvest ETF (NYSE: MJ) up 43% and the Horizons Medical Marijuana Life Sciences ETF (TSX: HMMJ) up around 51%.…

Read More